Cargando…
Concerning rates of laboratory‐confirmed antifungal‐resistant onychomycosis and tinea pedis: An online survey of podiatrists, United States
Autores principales: | Benedict, Kaitlin, Gold, Jeremy A. W., Jones, Carolynn T., Tushla, Lisa A., Lipner, Shari R., Joseph, Warren S., Tower, Dyane E., Elewski, Boni, Pappas, Peter G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667959/ https://www.ncbi.nlm.nih.gov/pubmed/38028688 http://dx.doi.org/10.1002/hsr2.1694 |
Ejemplares similares
-
Tinea Pedis
Publicado: (1953) -
A step in the right direction: the evidence for treating of tinea pedis and onychomycosis in people with diabetes
por: Matricciani, Lisa, et al.
Publicado: (2011) -
Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review
por: Matricciani, Lisa, et al.
Publicado: (2011) -
Tinea pedis: an updated review
por: Leung, Alexander KC, et al.
Publicado: (2023) -
Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
por: Benedict, Kaitlin, et al.
Publicado: (2022)